TransEnterix, a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced that it will exhibit and feature the Senhance surgical robot at the Clinical Congress 2016 of the American College of Surgeons (ACS).
The congress will be held on October 16-20, 2016 in Washington, DC.
“ACS is the largest gathering of global surgeons, and we are pleased to bring the Senhance System to exhibit at this major meeting for the first time,” said Mohan Nathan, Vice President of Global Marketing at TransEnterix.
“General surgical interest in the use of robotics is rapidly expanding, and the next wave of adoption will be driven by providing surgeons with new capabilities. Senhance is the first system that brings haptic force feedback, eye-sensing camera control, and responsible economics through reusable instrumentation to robotics.”
The Senhance will be available for surgeon evaluations at the congress. Surgeons may schedule system evaluations by signing up at the TransEnterix booth.
Non-surgeons may see demonstrations throughout the conference, and may also attend a group demonstration at the booth at 10am on Tuesday, October 18, 2016.
The Senhance carries the CE Mark for use in general surgery, gynecology, urology and thoracic surgery but is not available for sale in the US. TransEnterix is preparing a submission for U.S. FDA Clearance for the Senhance.
TransEnterix is a medical device company that is pioneering the use of robotics to improve minimally invasive surgery by addressing the clinical and economic challenges associated with current laparoscopic and robotic options.
The company is focused on the commercialization of the Senhance Surgical Robotic System, a multi-port robotic system that brings the advantages of robotic surgery to patients while enabling surgeons with innovative technology such as haptic feedback and eye sensing camera control.